skip to content

Clinical Neurosciences

Welcome to the Department of Clinical Neurosciences. 

Our mission is to improve the lives of people with neurological disorders. 

We are embedded within Cambridge University Hospitals, allowing our research questions to stem from problems we have encountered in the clinic, and to directly address the needs of patients and families. We work in partnership with the Departments of Psychiatry, Genetics and Paediatrics, to improve Brain and Mind Health, through life, together.

We investigate the mechanisms of brain disease and injury, to devise new diagnostics and treatments, as well as using large data to improve the way we deliver current treatments. Our work has already led to new treatments in use world-wide.

Professor Alasdair Coles
Head of Department

 


 



Latest news

Metabolic driver of Parkinson’s offers new target for treatment

30 April 2025

Researchers led by Dr Sung Min Son and Prof David Rubinsztein (UK DRI at Cambridge) have identified a key enzyme driving forms of Parkinson’s, and have shown how blocking it restores normal function in animal and cell models – offering a promising new drug target for the condition. In Parkinson’s, a protein known as alpha-...

Stefano Pluchino receives Experimental Medicine Trial Award from the International Progressive MS Alliance

29 April 2025

This international award has gone to three development projects in Canada and the United Kingdom, which will each receive €100,000 to begin planning for future clinical trials. Dr. Stefano Pluchino’s team is one of three projects to have received funding for clinical trial development projects as part of the International...

World-first trial indicates immunosuppression may help treat Parkinson's

23 April 2025

A groundbreaking trial, led from Cambridge, has revealed that immunosuppressing medicines show promise for the treatment of Parkinson’s disease, according to results presented this weekend at the world’s most prestigious neurodegeneration conference AD/PD. This trial is the first to show that broadly suppressing the immune...